Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the effects of adult day programs on older adults living with dementia and their family or friend caregivers across four Canadian provinces Alberta, British Columbia, Manitoba, and Ontario. The study aims to understand how day program attendance influences the quality of life and mental health of attendees and caregivers, as well as how different program characteristics and social identities relate to these outcomes. This observational study compares day program users and non-users to explore patterns of care and health outcomes in this population. Participants include older adults aged 65 and above with dementia who either attend an adult day program or receive other community-based continuing care services, along with their primary caregivers. The study gathers comprehensive data through surveys at baseline and follow-ups after one and two years, combined with health administrative records. Day program characteristics such as staffing and programming will be assessed, and participants will be grouped by levels of day program usage. During the study, participants will complete quality of life and mental health surveys at the start and at one- and two-year intervals. Researchers will also track cognitive and physical changes, time to admission into continuing care homes, and healthcare use including emergency visits and hospital stays over up to 2.5 years. This comprehensive approach aims to provide a detailed understanding of how adult day programs support older adults with dementia and their caregivers over time.
Actively Recruiting
Healthy Volunteer
Researchers are conducting a non-interventional, multi-site observational study to collect real-world data on the use of an autologous, hair follicle derived secretome topical cosmetic product. This product is applied following various medical aesthetic procedures to assess its effects on post-procedural erythema and recovery. The study is open-label and involves participants aged 18 to 60 undergoing specific aesthetic treatments. Participants plan to use the Acorn Autologous Hair Follicle Secretome cosmetic product as an adjunct after medical aesthetic procedures such as laser resurfacing ablative or non-ablative, Tixel treatment of the face, and treatment of acne or surgical scars combined with other procedures like microneedling or ablative laser. Some scalp treatments and Ellacor procedures are closed to enrollment. The study does not involve any experimental interventions but observes the real-world application of this topical product. During the study, participants will be monitored for symptoms and downtime after their procedures using questionnaires over 1 to 7 days post-treatment. Researchers will collect data on post-procedure symptoms and recovery time to evaluate the products impact. The total study period extends until February 2027, with ongoing assessments at specified intervals to capture real-world outcomes and safety information.